News | August 07, 2024
Gland Pharma posts 16% revenue growth in Q1 FY25
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
A one-time dose of DURVEQTIX has reduced bleeds post-treatment compared to standard of care with a median annualized bleed rate (ABR) of zero bleeds (range 0 to 9.9)
Reported profit after tax declined 19% year-on-year to Rs 76 crores
Contepo offers a unique mechanism of action and has the potential to address increasing antibiotic resistance and gaps in the current antibiotic treatment landscape
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
Subscribe To Our Newsletter & Stay Updated
